Germany's Bundestag passes a bill hiking drugmakers' patented-drug discount to 15.5%, aiming to cut €16.3B from 2027 health spending.

Patients, hospitals and drugmakers will shoulder the savings burden

German lawmakers passed a bill that would more than double the discount on branded medicines drugmakers must provide the government